Nabeth Pierre, Perrier-Gros-Claude Jean-David, Juergens-Behr Ann, Dromigny Jacques-Albert
Unité d'Epidémiologie, Institut Pasteur de Dakar, Dakar, Senegal.
Scand J Infect Dis. 2005;37(6-7):497-9. doi: 10.1080/00365540510038956.
We conducted a study in order to confirm the eligibility of fosfomycin trometamol as an alternative treatment to quinolones for urinary tract infections. Among 102 quinolone-resistant Enterobacteriaceae strains, resistance rates to first line-prescribed antibiotics were above 77%. The resistance rate to fosfomycin was 2%.
我们开展了一项研究,以确认磷霉素氨丁三醇作为喹诺酮类药物治疗尿路感染替代疗法的适用性。在102株对喹诺酮耐药的肠杆菌科菌株中,对一线处方抗生素的耐药率高于77%。对磷霉素的耐药率为2%。